Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.

Chrisandra Shufelt,B. Delia Johnson,Sarah L. Berga,Glenn D. Braunstein,Steven E. Reis,Vera Bittner,Yuching Yang,Carl J. Pepine,Barry L. Sharaf,George Sopko,Sheryl F. Kelsey,C. Noel Bairey Merz

Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.

2011

Chrisandra Shufelt
B. Delia Johnson
Sarah L. Berga
Glenn D. Braunstein
Steven E. Reis
Vera Bittner
Yuching Yang
Carl J. Pepine
Barry L. Sharaf
George Sopko
Sheryl F. Kelsey
C. Noel Bairey Merz

Objective To assess the relationship of timing of hormone therapy (HT) use with angiographic coronary artery disease (CAD) and cardiovascular disease (CVD) events in women with natural versus surgical menopause.

Keywords:

Menopause
Diabetes mellitus
Ischemia
Severity of illness
Hormone therapy
Coronary artery disease
Surgical Menopause
Disease
Cardiology
Internal medicine
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations